EUVIMEDEUVIMED entdecken
Crossref

The CREscendoing promise of HDAC targeting to limit atherosclerosis

Máté G Kiss, Christoph J Binder

Immunity · 2025

DOI: 10.1016/j.immuni.2025.02.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Máté G Kiss und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: mate.kiss@meduniwien.ac.at. Hauptthemen laut MEDLINE: Atherosclerosis, Histone Deacetylases, Repressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Leducq Foundation, Austrian Science Fund, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The factors that modulate the inflammatory response in atherosclerosis are not well defined. In this issue of Immunity, Asare et al. examine the impact of a cis-regulatory element (CRE) that controls expression of HDAC9 and find that HDAC9-mediated deacetylation of NLRP3 might be the mechanism by which genetic variants in this conserved CRE influence the inflammation associated with human atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisHistone DeacetylasesRepressor ProteinsHumansAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinInflammationMiceHistone Deacetylase Inhibitors

Substanzen

Histone DeacetylasesNLR Family, Pyrin Domain-Containing 3 ProteinRepressor ProteinsHDAC9 protein, humanHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: mate.kiss@meduniwien.ac.at.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: christoph.binder@meduniwien.ac.at.

Förderung

  • Leducq Foundation
  • Austrian Science Fund
  • European Commission
  • Austrian Research Promotion Agency
  • Horizon Europe

Zitieren

APA

Kiss, M. G., & Binder, C. J. (2025). The CREscendoing promise of HDAC targeting to limit atherosclerosis. Immunity. https://doi.org/10.1016/j.immuni.2025.02.010

Vancouver

Kiss MG, Binder CJ. The CREscendoing promise of HDAC targeting to limit atherosclerosis. Immunity. 2025. doi:10.1016/j.immuni.2025.02.010

BibTeX
@article{Kiss2025,
  author = {Kiss, Máté G and Binder, Christoph J},
  title = {The CREscendoing promise of HDAC targeting to limit atherosclerosis},
  journal = {Immunity},
  year = {2025},
  doi = {10.1016/j.immuni.2025.02.010}
}
Kostenlos starten →